Resources

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease that affects approximately 13 per 100,000 individuals. Although many potential mechanisms for ALS have been found using animal and in vitro cell models, the translation of […]

Spring 2021 In addition to our proprietary platforms  NerveSim® and BrainSim®, we are excited to announce the expansion of our SimLab Services: advanced neuronal monoculture and co-culture models. Our team of neuroscientists and biomedical engineers use state-of-the-art […]

GiveNOLA Day is a philanthropic day of giving to inspire people to give generously to nonprofits and make our Southeast Louisiana community thrive.  AxoSim is committed to investing in the future of New Orleans and […]

January 12, 2021 AxoSim’s Research Scientist Wesley Anderson published a review paper with Springer Nature’s In Vitro Cellular & Developmental Biology – Animal on advances in 3D neuronal microphysiological systems, the technology that powers AxoSim’s […]

On Wednesday, January 20th, 2021, at 11:10 am ET, AxoSim’s Chief Science Officer, Michael J. Moore, PhD, will be presenting at The National Academy of Science’s Workshop: Microphysiological Systems: Bridging Human and Animal Research. His […]

December 10, 2020 We present a nontraditional fabrication technique for the realization of three-dimensional (3D) microelectrode arrays (MEAs) capable of interfacing with 3D cellular networks in vitro. The technology uses cost-effective makerspace microfabrication techniques to fabricate the 3D […]

2020 has been a rough year in so many ways – but this year, we’ve also seen many outstanding advances here at AxoSim and great progress in the microphysiological systems (MPS) field, in general.  MPS […]

On Tuesday, December 8th, at 9am EST, AxoSim Consulting VP of Scientific Affairs, Thomas Hartung, MD, PhD, will be speaking on a Nature Research Custom Media Webcast: Translating Neurological Stem Cell Research into Therapies for […]

BENSON CAPITAL PARTNERS ANNOUNCES FIRST INVESTMENT IN AXOSIM, INC. AxoSim, Inc, Provider of BrainSim™ and NerveSim™ Neurological Drug Discovery Platforms Teams with Benson Capital Partners and Jefferson Capital Partners For Immediate Release: November 5, 2020 […]

October 30, 2020 –Two grants from the DoD Congressionally Directed Medical Research Program and the National Institutes of Health awarded to AxoSim–  –The CDMRP grant will support the development of a ALS NerveSim™ model to […]